{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:04:13Z","timestamp":1768935853612,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"DOI":"10.7759\/cureus.101880","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:02:47Z","timestamp":1768885367000},"source":"Crossref","is-referenced-by-count":0,"title":["Reversible Isolated Opsoclonus in a Patient With Gastric Cancer and Antibodies to Glutamic Acid Decarboxylase and Myelin Oligodendrocyte Glycoprotein"],"prefix":"10.7759","author":[{"given":"Alekhya","family":"Bommireddipalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arin","family":"Boghoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aengela Jihyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Yco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Karadanaian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio K","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Opsoclonus","author":"Margolin E","year":"2025","unstructured":"Margolin E, Kaur K, Jeeva-Patel T. Opsoclonus. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001153","article-title":"Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective","volume":"9","author":"Rossor T","year":"2022","unstructured":"Rossor T, Yeh EA, Khakoo Y, et al.. Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol Neuroimmunol Neuroinflamm. 2022, 9:10.1212\/NXI.0000000000001153","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211003486","article-title":"GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions","volume":"14","author":"Tsiortou P","year":"2021","unstructured":"Tsiortou P, Alexopoulos H, Dalakas MC. GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions. Ther Adv Neurol Disord. 2021, 14:10.1177\/17562864211003486","journal-title":"Ther Adv Neurol Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa A","year":"2024","unstructured":"Uzawa A, Oertel FC, Mori M, Paul F, Kuwabara S. NMOSD and MOGAD: an evolving disease spectrum. Nat Rev Neurol. 2024, 20:602-19. 10.1038\/s41582-024-01014-1","journal-title":"Nat Rev Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-006339","article-title":"Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies","volume":"2012","author":"Bhandari HS","year":"2012","unstructured":"Bhandari HS. Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies. BMJ Case Rep. 2012, 2012:10.1136\/bcr-2012-006339","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.10.024","article-title":"Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies","volume":"359","author":"Vale TC","year":"2015","unstructured":"Vale TC, Pedroso JL, Alqu\u00e9res RA, Dutra LA, Barsottini OG. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies. J Neurol Sci. 2015, 359:21-3. 10.1016\/j.jns.2015.10.024","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.03.005","article-title":"Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase","volume":"110","author":"Markakis I","year":"2008","unstructured":"Markakis I, Alexiou E, Xifaras M, Gekas G, Rombos A. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. Clin Neurol Neurosurg. 2008, 110:619-21. 10.1016\/j.clineuro.2008.03.005","journal-title":"Clin Neurol Neurosurg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o H","year":"2015","unstructured":"Ari\u00f1o H, H\u00f6ftberger R, Gresa-Arribas N, et al.. Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol. 2015, 72:874-81. 10.1001\/jamaneurol.2015.0749","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/545490","article-title":"\"Dancing eye syndrome\" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer","volume":"2014","author":"Laroumagne S","year":"2014","unstructured":"Laroumagne S, Elharrar X, Coiffard B, Plojoux J, Dutau H, Breen D, Astoul P. \"Dancing eye syndrome\" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer. Case Rep Med. 2014, 2014:10.1155\/2014\/545490","journal-title":"Case Rep Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518771872","article-title":"Ocular flutter as presenting manifestation of pediatric MOG antibody-associated demyelination: a case report","volume":"25","author":"Breza M","year":"2019","unstructured":"Breza M, Smyrni N, Koutsis G, et al.. Ocular flutter as presenting manifestation of pediatric MOG antibody-associated demyelination: a case report. Mult Scler J. 2019, 25:122-5. 10.1177\/1352458518771872","journal-title":"Mult Scler J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-023-01610-9","article-title":"Opsoclonus-myoclonus-ataxia syndrome due to COVID-19","volume":"23","author":"Adamaszek M","year":"2024","unstructured":"Adamaszek M, Langner S, Mehrholz J, Heiinrich A. Opsoclonus-myoclonus-ataxia syndrome due to COVID-19. Cerebellum. 2024, 23:1245-8. 10.1007\/s12311-023-01610-9","journal-title":"Cerebellum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102862","article-title":"Opsoclonus myoclonus syndrome in a postpartum period","volume":"50","author":"Adhikari S","year":"2021","unstructured":"Adhikari S, Thuringer A, Maali L, Jassam Y. Opsoclonus myoclonus syndrome in a postpartum period. Mult Scler Relat Disord. 2021, 50:10.1016\/j.msard.2021.102862","journal-title":"Mult Scler Relat Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.52301","article-title":"Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD","volume":"12","author":"Kwon YN","year":"2025","unstructured":"Kwon YN, Tisavipat N, Guo Y, et al.. Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD. Ann Clin Transl Neurol. 2025, 12:861-70. 10.1002\/acn3.52301","journal-title":"Ann Clin Transl Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller L","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001, 124:437-43. 10.1093\/brain\/124.2.437","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.1173","article-title":"Adult-onset opsoclonus-myoclonus syndrome","volume":"69","author":"Klaas JP","year":"2012","unstructured":"Klaas JP, Ahlskog JE, Pittock SJ, et al.. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012, 69:1598-607. 10.1001\/archneurol.2012.1173","journal-title":"Arch Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03881.x","article-title":"Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma","volume":"19","author":"Biotti D","year":"2012","unstructured":"Biotti D, Viaccoz A, Olivier N, Tilikete C, Rogemond V, Honnorat J, Vighetto A. Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma. Eur J Neurol. 2012, 19:144-5. 10.1111\/j.1468-1331.2012.03881.x","journal-title":"Eur J Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23131","article-title":"Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma","volume":"58","author":"Madrid AM","year":"2012","unstructured":"Madrid AM, Rubin CM, Kohrman M, Pytel P, Cohn SL. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma. Pediatr Blood Cancer. 2012, 58:472-4. 10.1002\/pbc.23131","journal-title":"Pediatr Blood Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60452","article-title":"Opsoclonus-myoclonus with anti-YO antibodies revealing breast cancer: a case report","volume":"16","author":"Samah Y","year":"2024","unstructured":"Samah Y, Sahar B, Mebrouk Y. Opsoclonus-myoclonus with anti-YO antibodies revealing breast cancer: a case report. Cureus. 2024, 16:10.7759\/cureus.60452","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2022.107849","article-title":"Gastric adenocarcinoma: a one-of-a-kind etiology of autoimmune paraneoplastic encephalitis","volume":"102","author":"Trujillo-Guerrero L","year":"2023","unstructured":"Trujillo-Guerrero L, V\u00e1squez-Garcia S, Ram\u00edrez-Giraldo C. Gastric adenocarcinoma: a one-of-a-kind etiology of autoimmune paraneoplastic encephalitis. Int J Surg Case Rep. 2023, 102:10.1016\/j.ijscr.2022.107849","journal-title":"Int J Surg Case Rep"},{"key":"ref20","article-title":"Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach","volume":"91","author":"Kikuchi H","year":"2000","unstructured":"Kikuchi H, Yamada T, Okayama A, et al.. Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach. Fukuoka Igaku Zasshi. 2000, 91:104-9.","journal-title":"Fukuoka Igaku Zasshi"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(01)00467-1","article-title":"Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma","volume":"185","author":"Meglic B","year":"2001","unstructured":"Meglic B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001, 185:135-8. 10.1016\/s0022-510x(01)00467-1","journal-title":"J Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1211814","article-title":"Case report: reversible brain atrophy with low titer anti-amphiphysin antibodies related to gastric adenocarcinoma","volume":"14","author":"Amano R","year":"2023","unstructured":"Amano R, Kim YJ, Yoshida T, Hara M, Nakajima H, Ohtsuka T, Yazawa M. Case report: reversible brain atrophy with low titer anti-amphiphysin antibodies related to gastric adenocarcinoma. Front Neurol. 2023, 14:10.3389\/fneur.2023.1211814","journal-title":"Front Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2014.06.001","article-title":"Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor","volume":"7","author":"Al-Harbi T","year":"2014","unstructured":"Al-Harbi T, Al-Sarawi A, Binfalah M, Dermime S. Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor. Hematol Oncol Stem Cell Ther. 2014, 7:116-9. 10.1016\/j.hemonc.2014.06.001","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2017-0081","article-title":"Paraneoplastic movement disorders","volume":"29","author":"Pop\u0142awska-Domaszewicz K","year":"2018","unstructured":"Pop\u0142awska-Domaszewicz K, Florczak-Wyspia\u0144ska J, Kozubski W, Michalak S. Paraneoplastic movement disorders. Rev Neurosci. 2018, 29:745-55. 10.1515\/revneuro-2017-0081","journal-title":"Rev Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-021-01359-z","article-title":"Advances in the pathogenesis of auto-antibody-induced cerebellar synaptopathies","volume":"22","author":"Mitoma H","year":"2023","unstructured":"Mitoma H, Manto M. Advances in the pathogenesis of auto-antibody-induced cerebellar synaptopathies. Cerebellum. 2023, 22:129-47. 10.1007\/s12311-021-01359-z","journal-title":"Cerebellum"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90406-y","article-title":"Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cell firing","volume":"116","author":"Litwak J","year":"1990","unstructured":"Litwak J, Mercugliano M, Chesselet M, et al.. Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cell firing. Neurosci Lett. 1990, 116:179-83. 10.1016\/0304-3940(90)90406-y","journal-title":"Neurosci Lett"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.01.038","article-title":"Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations","volume":"362","author":"Shaikh AG","year":"2016","unstructured":"Shaikh AG, Wilmot G. Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations. J Neurol Sci. 2016, 362:169-73. 10.1016\/j.jns.2016.01.038","journal-title":"J Neurol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.02.005","article-title":"GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis","volume":"46","author":"Mandolesi G","year":"2012","unstructured":"Mandolesi G, Grasselli G, Musella A, et al.. GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis. Neurobiol Dis. 2012, 46:414-24. 10.1016\/j.nbd.2012.02.005","journal-title":"Neurobiol Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2016.3.20150596","article-title":"Anti-glutamic acid decarboxylase antibody positive neurological syndromes","volume":"21","author":"Tohid H","year":"2016","unstructured":"Tohid H. Anti-glutamic acid decarboxylase antibody positive neurological syndromes. Neurosciences (Riyadh). 2016, 21:215-22. 10.17712\/nsj.2016.3.20150596","journal-title":"Neurosciences (Riyadh)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450338-reversible-isolated-opsoclonus-in-a-patient-with-gastric-cancer-and-antibodies-to-glutamic-acid-decarboxylase-and-myelin-oligodendrocyte-glycoprotein","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:02:48Z","timestamp":1768885368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450338-reversible-isolated-opsoclonus-in-a-patient-with-gastric-cancer-and-antibodies-to-glutamic-acid-decarboxylase-and-myelin-oligodendrocyte-glycoprotein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.101880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}